Summary
MetLife, Inc. announced on September 22, 2015, that its Board of Directors has authorized an additional $1 billion for the repurchase of its common stock. This significant capital return initiative increases the company's available repurchase authorization substantially, up from a previous remaining authorization of approximately $261 million. This move signals management's confidence in the company's financial health and its commitment to returning value to shareholders. Investors should view this increased share repurchase authorization as a positive indicator. It suggests that MetLife believes its stock is undervalued or that it has excess capital it wishes to deploy efficiently. The substantial increase in the repurchase program indicates a proactive approach to capital management and a potential boost to shareholder value through a reduction in outstanding shares, which can increase earnings per share.
Key Highlights
- 1MetLife's Board of Directors authorized an additional $1 billion for common stock repurchases.
- 2The total available repurchase authorization now stands at $1 billion.
- 3This represents a significant increase from the prior remaining authorization of approximately $261 million.
- 4The announcement was made via a news release filed on September 22, 2015.
- 5This action demonstrates a commitment by MetLife to return capital to shareholders.
- 6The company likely believes its stock is trading at an attractive valuation or has excess capital to deploy.